We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TGA Expands Drug-Tampering Recalls to Arrow, Sandoz
TGA Expands Drug-Tampering Recalls to Arrow, Sandoz
Following further reports of drug tampering, Australia’s Therapeutic Goods Administration expanded an ongoing recall to include Arrow Pharmaceuticals and Novartis’ Sandoz.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor